Pulmonary Vein Stenosis—Balloon Angioplasty Versus Stenting

Almakadma, Abdul Hakim; Sarma, Dhruv; Hassett, Leslie; Miranda, William R.; Alkhouli, Mohamad; Reeder, Guy S.; Munger, Thomas M.; Packer, Douglas L.; Simard, Trevor; Holmes, David R.

doi:10.1016/j.jacep.2022.08.008

Cited by 19 publications

(11 citation statements)

References 52 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Compared to surgical treatment, endoluminal interventions are less invasive and have significant short-term efficacy. [4,64,108] However, the restenosis rate is high. The pathogenesis of restenosis after balloon angioplasty (BA) involves an elastic recoil and typically occurs at an early stage after angioplasty.…”

Section: Catheter-based Interventionsmentioning

confidence: 99%

“…[22,30,56,109,110] For FM-PVS, the ISR has been identified in up to 24% to 50% of cases during short-term follow-up in some small sample-size case studies. [54,55,111] Recently, a meta-analysis by Almakadma et al [4] has enrolled 4 studies with a total of 340 patients with 579 PV interventions (225 BAs and 354 stentings; mean follow-up, 13–69 month) and shown the overall restenosis rate of 22.3% after stenting and 54% after BA. Drug-eluting stent application appears to reduce the incidence of restenosis.…”

Section: Treatment Of Pvsmentioning

confidence: 99%

“…However, restenosis following procedures (surgical and interventional treatment) is a tricky situation. [4,5] We herein review the embryology, anatomy, etiology, classification, diagnosis, and management of PVS to enhance understanding and awareness of this disease, which has a poor prognosis.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Pulmonary Vein Stenosis: A Review

Jia

Wang

et al. 2023

Cardiology Discovery

View full text Add to dashboard Cite

Pulmonary vein stenosis (PVS) is an extremely rare and lethal disease caused by multiple etiologies. PVS has a bimodal distribution in the population, affecting children and adults. Congenital PVS is the usual PVS type in children, which sometimes develops after cardiothoracic surgery. Acquired PVS, in turn, is the most common PVS type in adults. A review of the relevant literature has shown that PVS after radiofrequency ablation of atrial fibrillation is the most common, as well as that caused by compression of proliferative fibrous tissues or tumor in the mediastinum (eg, PVS caused by fibrosing mediastinitis, lung tumors, metastases, etc). This article provides a comprehensive review of PVS in terms of embryology and anatomy, etiology and triggers, classification, clinical symptoms and signs, treatment, and prognosis, intending to promote the understanding and treatment of this disease.

show abstract

Section: Catheter-based Interventionsmentioning

confidence: 99%

Section: Treatment Of Pvsmentioning

confidence: 99%

See 1 more Smart Citation

Pulmonary Vein Stenosis: A Review

Jia

Wang

et al. 2023

Cardiology Discovery

View full text Add to dashboard Cite

show abstract

“…These can lead to the occlusion of smaller arteries, such as the brain arterioles, and thus causes ischemic injuries. One option to restore blood circulation is percutaneous angioplasty, which consists of introducing a balloon within a peripheral artery, bringing it to the pathological artery, inflating it, compressing the atheromatous plaque, and restoring the artery lumen [4,5]. This procedure is usually associated with using a stent that keeps open the lumen of the vessel [5].…”

Section: Introductionmentioning

confidence: 99%

“…One option to restore blood circulation is percutaneous angioplasty, which consists of introducing a balloon within a peripheral artery, bringing it to the pathological artery, inflating it, compressing the atheromatous plaque, and restoring the artery lumen [4,5]. This procedure is usually associated with using a stent that keeps open the lumen of the vessel [5]. Nevertheless, in response to the injury of the vessel wall, the removal of the endothelium, and the presence of the stent, the vessel often develops restenosis [6].…”

Section: Introductionmentioning

confidence: 99%

Current biofabrication methods for vascular tissue engineering and an introduction to biological textiles

Kawecki

L’Heureux

2023

Biofabrication

View full text Add to dashboard Cite

Cardiovascular diseases are the leading cause of mortality in the world and encompass several important pathologies, including atherosclerosis. In the cases of severe vessel occlusion, surgical intervention using bypass grafts may be required. Synthetic vascular grafts provide poor patency for small diameter applications (< 6 mm) but are widely used for hemodialysis access and, with success, larger vessel repairs. In very small vessels, such as coronary arteries, synthetics outcomes are unacceptable, leading to the exclusive use of autologous (native) vessels despite their limited availability and, sometimes, quality. Consequently, there is a clear clinical need for a small-diameter vascular graft that can provide outcomes similar to native vessels. Many tissue-engineering approaches have been developed to offer native-like tissues with the appropriate mechanical and biological properties in order to overcome the limitations of synthetic and autologous grafts. This review overviews current scaffold-based and scaffold-free approaches developed to biofabricate tissue-engineered vascular grafts (TEVGs) with an introduction to the biological textile approaches. Indeed, these assembly methods show a reduced production time compared to processes that require long bioreactor-based maturation steps. Another advantage of the textile-inspired approaches is that they can provide better directional and regional control of the TEVG mechanical properties.

show abstract